NCT02073409 PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis Status ENROLLING_BY_INVITATION Phase N/A
NCT02070744 Study to Evaluate Safety and Efficacy of VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation With an Open-Label Expansion Status COMPLETED Phase PHASE2
NCT02054156 OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis Status COMPLETED Phase PHASE3
NCT02048592 Impact of Immunonutrition on the Patients With Cystic Fibrosis Status UNKNOWN Phase PHASE4
NCT02048163 Intermittent Versus Continuous Infusion Meropenem in Cystic Fibrosis Status WITHDRAWN Phase N/A
NCT02029521 Supplementation of Oral Reduced Glutathione in Pediatric Cystic Fibrosis Patients Status COMPLETED Phase NA
NCT02015663 Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles Status TERMINATED Phase PHASE4
NCT02015507 An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on Ivacaftor and VX-661 in Combination With Ivacaftor Status COMPLETED Phase PHASE1
NCT02003079 Evaluating the Impact of Chronic Rhinosinusitis on the Health-Related Quality of Life Among Adults With Cystic Fibrosis Status COMPLETED Phase N/A
NCT01991028 A Study to Investigate Lung Deposition of Radiolabelled OligoG Status COMPLETED Phase PHASE2